Development of a Hampton University Program for Novel Breast Cancer Imaging and Therapy Research
Abstract
Clinical data show that there is a strong correlation between the cosmetic outcome of women with early stage breast cancers treated with MSB applicator and the spacing between the MammoSite balloon surface and the skin. Many woman are not able to take advantage of MSB because of inadequate balloon-to-skin distances. The implementation of a thin customizable shielding layer to the MammoSite procedure will allow dynamic control over the skin dose overlying the MammoSite balloon. Dose distribution may be monitored using a combination of methods that includes usage of a gamma camera detector system and scintillating fiber technology. Jefferson Lab's upgraded gamma camera system for BSGI may be used for imaging and dosimetric studies during IB. It will allow in real time verifying that breast skindose does not exceed the safety limits during the shielded MSB and hence also the shielding powder placement in the balloon implanted breast (phantom). The objective of this project is to develop innovative techniques and advanced technologies surround the IB methodology to facilitate more women taking advantage of APBland therefore also of BCT to reduce breast cancer recurrence and increase survival expectancy. HU faculty and students will be integrally involved in research to advance breast cancer treatment and improve patient outcomes collaborating with a national lab and a medical school gaining hands-on experience in moving technology from bench to bedside while building capabilities to HU to successfully compete for and conduct breast cancer research.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 01, 2013
- Accession Number
- ADA580564
Entities
People
- Benjamin Welch
- Drew Weisenberger
- Nicholas J. Kenney
- Richard Brittan
Organizations
- Hampton University